Andreas Meier MD

Dr. Andreas Meier studied medicine and completed his doctorate degree at the University of Goettingen, Germany. At the same university he proceeded to his postgraduate training. During his residency as a member of the faculty staff he spent time in the areas of psychiatry, neurology and sleep medicine. In 2007 Andreas joined pharmaceutical industry and has since held various positions of increasing responsibility at different organizations including GlaxoSmithKline, AbbVie, and Pfizer across early and late stage clinical development. During his career he has been primarily focused on clinical development in neurodegenerative disorders, schizophrenia and orphan diseases. Currently Andreas holds the position of Sr. Medical Director with focus on neurocognitive disorders and pain at Biogen.